|
[1]
|
Weigel, D., Jurgens, G., Kuttner, F., Seifert, E. and Jackle, H. (1989) The Homeotic Gene Fork Head Encodes a Nuclear Protein and Is Expressed in the Terminal Regions of the Drosophila Embryo. Cell, 57, 645-658.
|
|
[2]
|
Wang, S., Li, G.X., Tan, C.C., He, R., Kang, L.J., Lu, J.T., et al. (2019) FOXF2 Reprograms Breast Cancer Cells into Bone Metastasis Seeds. Nature Communications, 10, Article No. 2707. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Nik, A.M., Johansson, J.A., Ghiami, M., Reyahi, A. and Carlsson, P. (2016) Foxf2 Is Required for Secondary Palate Development and Tgfβ Signaling in Palatal Shelf Mesenchyme. Developmental Biology, 415, 14-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Xu, J., Liu, H., Lan, Y., Aronow, B.J., Kalinichenko, V.V. and Jiang, R. (2016) A Shh-Foxf-Fgf18-Shh Molecular Circuit Regulating Palate Development. PLoS Genetics, 12, e1005769. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pierrou, S., Hellqvist, M., Samuelsson, L., Enerback, S. and Carlsson, P. (1994) Cloning and Characterization of Seven Human Forkhead Proteins: Binding Site Specificity and DNA Bending. The EMBO Journal, 13, 5002-5012. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Blixt, A., Mahlapuu, M., Bjursell, C., Darnfors, C., Johannesson, T., Enerback, S., et al. (1998) The Two-Exon Gene of the Human Forkhead Transcription Factor FREAC-2 (FKHL6) Is Located at 6p25.3. Genomics, 53, 387-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Hirata, H., Ueno, K., Shahryari, V., Deng, G., Tanaka, Y., Tabatabai, Z.L., et al. (2013) MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer. PLoS ONE, 8, e55502. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
van den Brink, G.R. and Rubin, D.C. (2013) Foxf2: A Mesenchymal Regulator of Intestinal Adenoma Development. Gastroenterology, 144, 873-876. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Gao, L., Chen, B., Li, J., Yang, F., Cen, X., Liao, Z., et al. (2017) Wnt/β-Catenin Signaling Pathway Inhibits the Proliferation and Apoptosis of U87 Glioma Cells via Different Mechanisms. PLoS ONE, 12, e0181346. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Zhou, S., Mizuno, S., Fau-Glowacki, J. and Glowacki, J. (2013) Wnt Pathway Regulation by Demineralized Bone Is Approximated by Both BMP-2 and TGF-β1 Signaling. Journal of Orthopaedic Research, 31, 554-560. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Tian, D., Shi, Y., Chen, D., Liu, Q. and Fan, F. (2017) The Wnt Inhibitor LGK-974 Enhances Radiosensitivity of HepG2 Cells by Modulating Nrf2 Signaling. International Journal of Oncology, 51, 545-554. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Gonzalez, D.M. and Medici, D. (2014) Signaling Mechanisms of the Epithelial-Mesenchymal Transition. Science Signaling, 7, re8.
|
|
[13]
|
Yu, S.B., Zhu, K., Lai, Y.M., Zhao, Z.F., Fan, J., Im, H.J., et al. (2013) ATF4 Promotes β-Catenin Expression and Osteoblastic Differentiation of Bone Marrow Mesenchymal Stem Cells. International Journal of Biological Sciences, 9, 256-266. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kim, S.E., Huang, H., Zhao, M., Zhang, X., Zhang, A., Semonov, M.V., et al. (2013) Wnt Stabilization of β-Catenin Reveals Principles for Morphogen Receptor-Scaffold Assemblies. Science, 340, 867-870.
|
|
[15]
|
MacDonald, B.T., Tamai, K. and He, X. (2009) Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases. Developmental Cell, 17, 9-26. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Nik, A.M., Reyahi, A., Ponten, F. and Carlsson, P. (2013) Foxf2 in Intestinal Fibroblasts Reduces Numbers of Lgr5+ Stem Cells and Adenoma Formation by Inhibiting Wnt Signaling. Gastroenterology, 144, 1001-1011. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Zhang, J., Liu, Y., Zhang, J., Cui, X., Li, G., Wang, J., et al. (2016) FOXQ1 Promotes Gastric Cancer Metastasis through Upregulation of Snail. Oncology Reports, 35, 3607-3613. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Chaffer, C.L., San Juan, B.P., Lim, E. and Weinberg, R.A. (2016) EMT, Cell Plasticity and Metastasis. Cancer and Metastasis Reviews, 35, 645-654. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Otani, K., Li, X., Arakawa, T., Chan, F.K.L. and Yu, J. (2013) Epigenetic-Mediated Tumor Suppressor Genes as Diagnostic or Prognostic Biomarkers in Gastric Cancer. Expert Review of Molecular Diagnostics, 13, 445-455. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Nieto, M.A. (2013) Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells. Science, 342, Article ID: 1234850.
|
|
[21]
|
Cristina Rotar, I., Muresan, D., Elena Dumitras, D., Popp Radu, A., Maria Petrisor, F. and Stamatian, F. (2016) E-Cadherin-160 C/A Genotypes and Cervical Intraepithelial Neoplasia. Journal of BUON, 21, 1184-1188.
|
|
[22]
|
Lee, G., Kim, H.J. and Kim, H.M. (2016) RhoA-JNK Regulates the E-Cadherin Junctions of Human Gingival Epithelial Cells. Journal of Dental Research, 95, 284-291. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., et al. (2004) Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis. Cell, 117, 927-939. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Wang, Q.S., Kong, P.Z., Li, X.Q., Yang, F. and Feng, Y.-M. (2017) FOXF2 Deficiency Promotes Epithelial-Mesenchymal Transition and Metastasis of Basal-Like Breast Cancer. Breast Cancer Research, 17, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Bartel, D.P. (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell, 116, 281-297. [Google Scholar] [CrossRef]
|
|
[26]
|
Freimer, J.W., Hu, T.J. and Blelloch, R. (2018) Decoupling the Impact of microRNAs on Translational Repression versus RNA Degradation in Embryonic Stem Cells. eLife, 7, e38014.
|
|
[27]
|
Bartel, D.P. (2018) Metazoan MicroRNAs. Cell, 173, 20-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Zhou, H., Guo, W., Zhao, Y., Wang, Y., Zha, R., Ding, J., et al. (2014) MicroRNA-26a Acts as a Tumor Suppressor Inhibiting Gallbladder Cancer Cell Proliferation by Directly Targeting HMGA2. International Journal of Oncology, 44, 2050-2058. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Huang, J., Zhang, S.Y., Gao, Y.M., Liu, Y.F., Liu, Y.B., Zhao, Z.G., et al. (2014) MicroRNAs as Oncogenes or Tumour Suppressors in Oesophageal Cancer: Potential Biomarkers and Therapeutic Targets. Cell Proliferation, 47, 277-286. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Guttilla, I.K. and White, B.A. (2009) Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells. The Journal of Biological Chemistry, 284, 23204-23216. [Google Scholar] [CrossRef]
|
|
[31]
|
Chiang, C.H., Hou, M.F. and Hung, W.C. (2013) Up-Regulation of miR-182 by β-Catenin in Breast Cancer Increases Tumorigenicity and Invasiveness by Targeting the Matrix Metalloproteinase Inhibitor RECK. Biochimica et Biophysica Acta, 1830, 3067-3076. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Liu, Z., Liu, J., Segura, M.F., Shao, C., Lee, P., Gong, Y., et al. (2012) MiR-182 Overexpression in Tumourigenesis of High-Grade Serous Ovarian Carcinoma. The Journal of Pathology, 228, 204-215. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Tsuchiyama, K., Ito, H., Taga, M., Naganuma, S., Oshinoya, Y., Nagano, K., et al. (2013) Expression of microRNAs Associated with Gleason Grading System in Prostate Cancer: miR-182-5p Is a Useful Marker for High Grade Prostate Cancer. The Prostate, 73, 827-834. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Segura, M.F., Hanniford, D., Menendez, S., Reavie, L., Zou, X., Alvarez-Diaz, S., et al. (2009) Aberrant miR-182 Expression Promotes Melanoma Metastasis by Repressing FOXO3 and Microphthalmia-Associated Transcription Factor. Proceedings of the National Academy of Sciences of the United States of America, 106, 1814-1819. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Jiang, L., Mao, P., Song, L., Wu, J., Huang, J., Lin, C., et al. (2010) miR-182 as a Prognostic Marker for Glioma Progression and Patient Survival. The American Journal of Pathology, 177, 29-38.
|
|
[36]
|
Zhang, Y., Wang, X., Wang, Z., Tang, H., Fan, H. and Guo, Q. (2015) miR-182 Promotes Cell Growth and Invasion by Targeting Forkhead Box F2 Transcription Factor in Colorectal Cancer. Oncology Reports, 33, 2592-2598. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Yu, J., Shen, W., Gao, B., Zhao, H., Xu, J. and Gong, B. (2017) MicroRNA-182 Targets FOXF2 to Promote the Development of Triple-Negative Breast Cancer. Neoplasma, 64, 209-215. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Wang, A., Jin, C., Li, H., Qin, Q. and Li, L. (2018) LncRNA ADAMTS9-AS2 Regulates Ovarian Cancer Progression by Targeting miR-182-5p/FOXF2 Signaling Pathway. International Journal of Biological Macromolecules, 120, 1705-1713. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Zhang, X., Ma, G., Liu, J. and Zhang, Y. (2017) MicroRNA-182 Promotes Proliferation and Metastasis by Targeting FOXF2 in Triple-Negative Breast Cancer. Oncology Letters, 14, 4805-4811. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Kundu, S.T., Byers, L.A., Peng, D.H., Roybal, J.D., Diao, L., Wang, J., et al. (2016) The miR-200 Family and the miR-183~96~182 Cluster Target Foxf2 to Inhibit Invasion and Metastasis in Lung Cancers. Oncogene, 35, 173-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Cogoi, S., Zorzet, S., Rapozzi, V., Geci, I., Pedersen, E.B. and Xodo, L.E. (2013) MAZ-Binding G4-Decoy with Locked Nucleic Acid and Twisted Intercalating Nucleic Acid Modifications Suppresses KRAS in Pancreatic Cancer Cells and Delays Tumor Growth in Mice. Nucleic Acids Research, 41, 4049-4064. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Izzo, M.W., Strachan, G.D., Stubbs, M.C. and Hall, D.J. (1999) Transcriptional Repression from the c-myc P2 Promoter by the Zinc Finger Protein ZF87/MAZ. The Journal of Biological Chemistry, 274, 19498-19506. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Ray, A. and Ray, B.K. (2015) Induction of Ras by SAF-1/MAZ through a Feed-Forward Loop Promotes Angiogenesis in Breast Cancer. Cancer Medicine, 4, 224-234. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Smits, M., Wurdinger, T., van het Hof, B., Drexhage, J.A., Geerts, D., Wesseling, P., et al. (2012) Myc-Associated Zinc Finger Protein (MAZ) Is Regulated by miR-125b and Mediates VEGF-Induced Angiogenesis in Glioblastoma. The FASEB Journal, 26, 2639-2647. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Yao, Y., Ma, J., Xue, Y., Wang, P., Li, Z., Li, Z., et al. (2015) MiR-449a Exerts Tumor-Suppressive Functions in Human Glioblastoma by Targeting Myc-Associated Zinc-Finger Protein. Molecular Oncology, 9, 640-656. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Karantzoulis-Fegaras, F., Antoniou, H., Lai, S.L., Kulkarni, G., D’Abreo, C., Wong, G.K., et al. (1999) Characterization of the Human Endothelial Nitric-Oxide Synthase Promoter. The Journal of Biological Chemistry, 274, 3076-3093. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Song, J., Mangold, M., Suske, G., Geltinger, C., Kanazawa, I., Sun, K., et al. (2001) Characterization and Promoter Analysis of the Mouse Gene for Transcription Factor Sp4. Gene, 264, 19-27. [Google Scholar] [CrossRef]
|
|
[48]
|
Luo, W., Zhu, X., Liu, W., Ren, Y., Bei, C., Qin, L., et al. (2016) MYC Associated Zinc Finger Protein Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Inducing Epithelial Mesenchymal Transition. Oncotarget, 7, 86420-86432. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Jiao, L., Li, Y., Shen, D., Xu, C.L., Wang, L.H., Huang, G., et al. (2013) The Prostate Cancer-up-Regulated Myc-Associated Zinc-Finger Protein (MAZ) Modulates Proliferation and Metastasis through Reciprocal Regulation of Androgen Receptor. Medical Oncology, 30, Article No. 570. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Zhu, X., Luo, W., Liang, W., Tang, F., Bei, C., Ren, Y., et al. (2016) Overexpression and Clinical Significance of MYC-Associated Zinc Finger Protein in Pancreatic Carcinoma. OncoTargets and Therapy, 9, 7493-7501. [Google Scholar] [CrossRef]
|
|
[51]
|
Ray, A., Dhar, S. and Ray, B.K. (2011) Control of VEGF Expression in Triple-Negative Breast Carcinoma Cells by Suppression of SAF-1 Transcription Factor Activity. Molecular Cancer Research, 9, 1030-1041. [Google Scholar] [CrossRef]
|
|
[52]
|
Franz, H., Greschik, H., Willmann, D., Ozretic, L., Jilg, C.A., Wardelmann, E., et al. (2015) The Histone Code Reader SPIN1 Controls RET Signaling in Liposarcoma. Oncotarget, 6, 4773-4789. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Song, J., Ugai, H., Nakata-Tsutsui, H., Kishikawa, S., Suzuki, E., Murata, T., et al. (2003) Transcriptional Regulation by Zinc-Finger Proteins Sp1 and MAZ Involves Interactions with the Same cis-Elements. International Journal of Molecular Medicine, 11, 547-553. [Google Scholar] [CrossRef]
|
|
[54]
|
Yu, Z.H., Lun, S.M., He, R., Tian, H.P., Huang, H.J., Wang, Q.S., et al. (2017) Dual Function of MAZ Mediated by FOXF2 in Basal-Like Breast Cancer: Promotion of Proliferation and Suppression of Progression. Cancer Letters, 402, 142-152. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Sotiriou, C. and Pusztai, L. (2009) Gene-Expression Signatures in Breast Cancer. The New England Journal of Medicine, 360, 790-800. [Google Scholar] [CrossRef]
|
|
[56]
|
Weigelt, B. and Reis-Filho, J.S. (2009) Histological and Molecular Types of Breast Cancer: Is There a Unifying Taxonomy? Nature Reviews Clinical Oncology, 6, 718-730. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Cheang, M.C., Chia, S.K., Voduc, D., Gao, D., Leung, S., Snider, J., et al. (2009) Ki67 Index, HER2 Status, and Prognosis of Patients with Luminal B Breast Cancer. Journal of the National Cancer Institute, 101, 736-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Goldhirsch, A., Wood, W.C., Coates, A.S., Gelber, R.D., Thurlimann, B. and Senn, H.J. (2011) Strategies for Subtypes—Dealing with the Diversity of Breast Cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Annals of Oncology, 22, 1736-1747. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Lo, P.K. (2018) FOXF2 Differentially Regulates Expression of Metabolic Genes in Non-Cancerous and Cancerous Breast Epithelial Cells. Trends in Diabetes and Metabolism, 1. [Google Scholar] [CrossRef]
|
|
[60]
|
Shi, W., Gerster, K., Alajez, N.M., Tsang, J., Waldron, L., Pintilie, M., et al. (2011) MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer. Cancer Research, 71, 2926-2937. [Google Scholar] [CrossRef]
|
|
[61]
|
Jain, M.V., Shareef, A., Likus, W., Cieslar-Pobuda, A., Ghavami, S. and Los, M.J. (2016) Inhibition of miR301 Enhances Akt-Mediated Cell Proliferation by Accumulation of PTEN in Nucleus and Its Effects on Cell-Cycle Regulatory Proteins. Oncotarget, 7, 20953-20965. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Zhang, T., Wan, J.G., Liu, J.B. and Deng, M. (2017) MiR-200c Inhibits Metastasis of Breast Tumor via the Downregulation of Foxf2. Genetics and Molecular Research: GMR, 16. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Kong, P.Z., Yang, F., Li, L., Li, X.Q. and Feng, Y.M. (2013) Decreased FOXF2 mRNA Expression Indicates Early-Onset Metastasis and Poor Prognosis for Breast Cancer Patients with Histological Grade II Tumor. PLoS ONE, 8, e61591. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Wang, Q.S., Kong, P.Z., Li, X.Q., Yang, F. and Feng, Y.M. (2015) FOXF2 Deficiency Promotes Epithelial-Mesenchymal Transition and Metastasis of Basal-Like Breast Cancer. Breast Cancer Research: BCR, 17, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Katoh, M., Igarashi, M., Fukuda, H., Nakagama, H. and Katoh, M. (2013) Cancer Genetics and Genomics of Human FOX Family Genes. Cancer Letters, 328, 198-206. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Cai, J., Tian, A.X., Wang, Q.S., Kong, P.Z., Du, X., Li, X.Q., et al. (2015) FOXF2 Suppresses the FOXC2-Mediated Epithelial-Mesenchymal Transition and Multidrug Resistance of Basal-Like Breast Cancer. Cancer Letters, 367, 129-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Kang, L.J., Yu, Z.H., Cai, J., He, R., Lu, J.T., Hou, C., et al. (2019) Reciprocal Transrepression between FOXF2 and FOXQ1 Controls Basal-Like Breast Cancer Aggressiveness. The FASEB Journal, 33, 6564-6573. [Google Scholar] [CrossRef]
|
|
[68]
|
Hnisz, D., Shrinivas, K., Young, R.A., Chakraborty, A.K. and Sharp, P.A. (2017) A Phase Separation Model for Transcriptional Control. Cell, 169, 13-23. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Boija, A., Klein, I.A., Sabari, B.R., Dall’Agnese, A., Coffey, E.L., Zamudio, A.V., et al. (2018) Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains. Cell, 175, 1842-1855.E16. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Lo, P.K. (2017) The Controversial Role of Forkhead Box F2 (FOXF2) Transcription Factor in Breast Cancer. PRAS Open, 1, No. 9.
|
|
[71]
|
Shi, Z., Liu, J., Yu, X., Huang, J., Shen, S., Zhang, Y., et al. (2016) Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients. Annals of Surgical Oncology, 23, 211-217. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Dou, C., Jin, X., Sun, L., Zhang, B., Han, M. and Li, T. (2017) FOXF2 Deficiency Promotes Hepatocellular Carcinoma Metastasis by Inducing Mesenchymal-Epithelial Transition. Cancer Biomarkers, 19, 447-454. [Google Scholar] [CrossRef]
|
|
[73]
|
Wang, L. and Di, L.J. (2015) Wnt/β-Catenin Mediates AICAR Effect to Increase GATA3 Expression and Inhibit Adipogenesis. The Journal of Biological Chemistry, 290, 19458-19468. [Google Scholar] [CrossRef]
|
|
[74]
|
Laxmidevi, L.B., Angadi, P.V., Pillai, R.K. and Chandreshekar, C. (2010) Aberrant β-Catenin Expression in the Histologic Differentiation of Oral Squamous Cell Carcinoma and Verrucous Carcinoma: An Immunohistochemical Study. Journal of Oral Science, 52, 633-640. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Jamieson, C., Sharma, M. and Henderson, B.R. (2014) Targeting the β-Catenin Nuclear Transport Pathway in Cancer. Seminars in Cancer Biology, 27, 20-29. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Thrasivoulou, C., Millar, M. and Ahmed, A. (2013) Activation of Intracellular Calcium by Multiple Wnt Ligands and Translocation of β-Catenin into the Nucleus: A Convergent Model of Wnt/Ca2+ and Wnt/β-Catenin Pathways. The Journal of Biological Chemistry, 288, 35651-35659. [Google Scholar] [CrossRef]
|
|
[77]
|
Yin, H., Sheng, Z., Zhang, X., Du, Y., Qin, C., Liu, H., et al. (2017) Overexpression of SOX18 Promotes Prostate Cancer Progression via the Regulation of TCF1, c-Myc, cyclin D1 and MMP-7. Oncology Reports, 37, 1045-1051. [Google Scholar] [CrossRef] [PubMed]
|
|
[78]
|
Li, Y.J., Wei, Z.M., Meng, Y.X. and Ji, X.R. (2005) β-Catenin Up-Regulates the Expression of cyclinD1, c-myc and MMP-7 in Human Pancreatic Cancer: Relationships with Carcinogenesis and Metastasis. World Journal of Gastroenterology, 11, 2117-2123. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
Bademci, G., Abad, C., Incesulu, A., Elian, F., Reyahi, A., Diaz-Horta, O., et al. (2019) FOXF2 Is Required for Cochlear Development in Humans and Mice. Human Molecular Genetics, 28, 1286-1297. [Google Scholar] [CrossRef] [PubMed]
|
|
[80]
|
Zhang, J., Zhang, C., Sang, L., Huang, L., Du, J. and Zhao, X. (2018) FOXF2 Inhibits Proliferation, Migration, and Invasion of Hela Cells by Regulating Wnt Signaling Pathway. Bioscience Reports, 38, BSR20180747. [Google Scholar] [CrossRef]
|
|
[81]
|
Higashimori, A., Dong, Y.J., Zhang, Y.Q., Kang, W., Nakatsu, G., Ng, S.S.M., et al. (2018) Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis. Cancer Research, 78, 1643-1656. [Google Scholar] [CrossRef]
|
|
[82]
|
Tian, H.P., Lun, S.M., Huang, H.J., He, R., Kong, P.Z., Wang, Q.S., et al. (2015) DNA Methylation Affects the SP1-Regulated Transcription of FOXF2 in Breast Cancer Cells. The Journal of Biological Chemistry, 290, 19173-19183. [Google Scholar] [CrossRef]
|
|
[83]
|
Herring, B.P., Hoggatt, A.M., Gupta, A. and Wo, J.M. (2019) Gastroparesis Is Associated with Decreased FOXF1 and FOXF2 in Humans, and Loss of FOXF1 and FOXF2 Results in Gastroparesis in Mice. Neurogastroenterology & Motility, 31, e13528. [Google Scholar] [CrossRef] [PubMed]
|
|
[84]
|
van der Heul-Nieuwenhuijsen, L., Dits, N.F. and Jenster, G. (2009) Gene Expression of Forkhead Transcription Factors in the Normal and Diseased Human Prostate. BJU International, 103, 1574-1580. [Google Scholar] [CrossRef]
|
|
[85]
|
Mendes, O., Kim, H.T., Lungu, G. and Stoica, G. (2007) MMP2 Role in Breast Cancer Brain Metastasis Development and Its Regulation by TIMP2 and ERK1/2. Clinical & Experimental Metastasis, 24, 341-351. [Google Scholar] [CrossRef] [PubMed]
|
|
[86]
|
Si, M. and Lang, J. (2018) The Roles of Metallothioneins in Carcinogenesis. Journal of Hematology & Oncology, 11, Article No. 107. [Google Scholar] [CrossRef] [PubMed]
|
|
[87]
|
van der Heul-Nieuwenhuijsen, L., Dits, N., Van Ijcken, W., de Lange, D. and Jenster, G. (2009) The FOXF2 Pathway in the Human Prostate Stroma. The Prostate, 69, 1538-1547. [Google Scholar] [CrossRef] [PubMed]
|
|
[88]
|
Schaefer, A., Jung, M., Mollenkopf, H.J., Wagner, I., Stephan, C., Jentzmik, F., et al. (2010) Diagnostic and Prognostic Implications of microRNA Profiling in Prostate Carcinoma. International Journal of Cancer, 126, 1166-1176. [Google Scholar] [CrossRef] [PubMed]
|
|
[89]
|
Mihelich, B.L., Khramtsova, E.A., Arva, N., Vaishnav, A., Johnson, D.N., Giangreco, A.A., et al. (2011) miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells. The Journal of Biological Chemistry, 286, 44503-44511. [Google Scholar] [CrossRef]
|